Under the BMA Act, the functions of the Board of Directors are to manage the affairs and business of the BMA and to determine the policy objectives and strategy of the Authority. The Board consists of eight non-executive directors appointed by the Minister of Finance from the various sectors of industry. In addition the Minister appoints the Chairman of the Board. The Chief Executive Officer is also a member of the Board and is appointed by the Minister on the recommendation of the Board. To enhance independence, Board members are appointed for terms ranging from three to five years. Board conflicts are strictly managed in accordance with the Act.
One of the non-Executive Directors is appointed as Deputy Chairman and chairs the Non-Executive Directors’ Committee. This committee is responsible for:
Alan Cossar |
Chairman Group Managing Director |
Darren Q. Johnston, CA |
Deputy Chairman |
Jeremy Cox, BSc, CPA |
CEO |
Walter A. Bell |
Chairman, Swiss Re America Holdings Corporation |
Anthony Joaquin, FCA |
Managing Partner, Ernst & Young (retired) |
Lynda Milligan-Whyte, BA, BEd, MPA, LLB |
Senior Partner, Lynda Milligan-Whyte & Associates |
E. Barclay Simmons |
Managing Partner, Attride-Stirling & Woloniecki |
Ronald Simmons, CA |
Partner, Moore, Stephens & Butterfield |
The Hon. Gerald Simons |
President & CEO, The Argus Group |
Tracy Tepper |
President & CEO, Lombard Odier Darier Hentsch Trust (Bermuda) Limited |